OTTO DAWN PARSELL (Sr VP, Clinical Development) received a stock award from TRICIDA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 9/14/2020ACC: 0001595585-20-000126
Officer· Sr VP, Clinical Development
Since Aug 2018
+4K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
4K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+4K
Price / share
—
Trade value
—
% of position
627.9%
9/10/2020
637.00→4.64K
Total
Net shares
+4K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/10/2020 | A · Award | +4K | — | — | 627.9% | 637.00 | 4.64K |
| Total | +4K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported